- Home
- PLRX vs VREX Comparison
PLRX vs VREX Comparison
Compare PLRX & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- VREX
- Stock Information
- Founded
- PLRX 2015
- VREX 2016
- Country
- PLRX United States
- VREX United States
- Employees
- PLRX N/A
- VREX N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- VREX Industrial Machinery/Components
- Sector
- PLRX Health Care
- VREX Technology
- Exchange
- PLRX Nasdaq
- VREX Nasdaq
- Market Cap
- PLRX 84.7M
- VREX 343.3M
- IPO Year
- PLRX 2020
- VREX N/A
- Fundamental
- Price
- PLRX $1.29
- VREX $8.80
- Analyst Decision
- PLRX Hold
- VREX Strong Buy
- Analyst Count
- PLRX 10
- VREX 2
- Target Price
- PLRX $9.79
- VREX $22.50
- AVG Volume (30 Days)
- PLRX 1.5M
- VREX 426.6K
- Earning Date
- PLRX 08-06-2025
- VREX 07-31-2025
- Dividend Yield
- PLRX N/A
- VREX N/A
- EPS Growth
- PLRX N/A
- VREX N/A
- EPS
- PLRX N/A
- VREX N/A
- Revenue
- PLRX N/A
- VREX $827,500,000.00
- Revenue This Year
- PLRX N/A
- VREX $0.73
- Revenue Next Year
- PLRX N/A
- VREX $4.40
- P/E Ratio
- PLRX N/A
- VREX N/A
- Revenue Growth
- PLRX N/A
- VREX N/A
- 52 Week Low
- PLRX $1.10
- VREX $6.76
- 52 Week High
- PLRX $16.10
- VREX $16.93
- Technical
- Relative Strength Index (RSI)
- PLRX 38.40
- VREX 60.51
- Support Level
- PLRX $1.13
- VREX $8.42
- Resistance Level
- PLRX $1.43
- VREX $8.92
- Average True Range (ATR)
- PLRX 0.11
- VREX 0.41
- MACD
- PLRX -0.01
- VREX 0.08
- Stochastic Oscillator
- PLRX 21.68
- VREX 91.37
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.